Pubblicazioni

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

D'Amico, Silvia; D'Alicandro, Valerio; Compagnone, Mirco; Tempora, Patrizia; Guida, Giusy; Romania, Paolo; Lucarini, Valeria; Melaiu, Ombretta; Falco, Michela; Algeri, Mattia; Pende, Daniela; Cifaldi, Loredana; Fruci, Doriana

Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas

2021 - JOURNAL FOR IMMUNOTHERAPY OF CANCER

Arnone, C. M.; Polito, V. A.; Mastronuzzi, A.; Carai, A.; Diomedi, F. C.; Antonucci, L.; Petrilli, L. L.; Vinci, M.; Ferrari, F.; Salviato, E.; Scarsella, M.; De Stefanis, C.; Weber, G.; Quintarelli, C.; De Angelis, B.; Brenner, M. K.; Gottschalk, S.; Hoyos, V.; Locatelli, F.; Caruana, I.; Del Bufalo, F.

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY